Antibodies to Neuropeptides: Biological Effects and Mechanisms of Action

  • F. J. H. Tilders
  • J. W. A. M. van Oers
  • A. White
  • F. Menzaghi
  • A. Burlet
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 274)


After the discovery of the conventional neurotransmitters, it became clear that peptides also play an important role as intercellular messengers in the nervous system. Over the past three decades, hundreds of biologically active peptides have been isolated from or identified in brain tissue. These studies were usually directly followed by the identification of the sites of peptide production, storage and release with the aid of radioimmunoassays, immunocytochemistry, and hybridochemistry. In addition to such data, ligand binding studies may generate cues as to the organs or cells that may be influenced by a particular neuropeptide. In contrast to the relative ease with which the biological effects of a peptide are established, studies on the physiological roles of a peptide are complicated and often hampered by the lack of appropriate tools. It is conceivable that a physiological role of a neuropeptide is demonstrated most convincingly by studying the derangements caused by blockade of peptidergic signal transfer by the use of specific peptide receptor antagonists.


Glutamate Decarboxylase Neuronal Uptake Corticosterone Secretion Antibody Uptake Noradrenergic Axon 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Nieschlag, E. (ed) Immunization with Hormones in Reproduction Research ,North Holland Publishers, Amsterdam, 1975.Google Scholar
  2. 2.
    Frazer, H.M., Active immunization of stumptailed macaquo monkeys against luteinizing hormone releasing hormone and in effects on menstrual cycles, ovarian steroids and positive feedback, J Reprod Immunol 5: 173–183, 1983.CrossRefGoogle Scholar
  3. 3.
    Linton, EA., FJ.H. Tilders, S. Hodgkinson, F. Berkenbosch, I. Vermes, and PJ. Lowry, Stress-induced secretion of adrenocorticotropin in rats is inhibited by administration of antisera to ovine corticotropin-releasing factor and vasopressin, Endocrinology 116: 966–970, 1985.PubMedCrossRefGoogle Scholar
  4. 4.
    van Oers, J.WA.M., FJ.H. Tilders, and F. Berkenbosch, Characterization and biological activity of a rat monoclonal antibody to rat/human corticotropin-releasing factor, Endocrinology 124:1239–1246,1989.PubMedCrossRefGoogle Scholar
  5. 5.
    van Oers, J.WA.M., FJ.H. Tilders, and F. Berkenbosch, Acute and long-term suppression of stress-induced ACTH secretion by a rat monoclonal antibody to corticotropin releasing factor, In E.E. Müller and R.M. MacLeod (eds) Neuroendocrine Perspectives, Volume 6 ,Springer-Verlag, New York, 287–292, 1989.CrossRefGoogle Scholar
  6. 6.
    Van Leeuwen, F., Pitfalls in immunocytochemistry with special reference to the specificity problems in the localization of neuropeptides, Am JAnat 175: 363–377,1986.CrossRefGoogle Scholar
  7. 7.
    Berkenbosch, F., and FJ.H. Tilders, A quantitative approach to cross reaction problems in immunocytochemistry, Neuroscience 23: 823–826,1987.PubMedCrossRefGoogle Scholar
  8. 8.
    Fleischer, N., J.R. Givens, K. Abe, W.E. Nicholson, and G.W. Liddle, Studies of ACTH antibodies and their reactions with inactive analogues of ACTH, Endocrinology 78: 1067–1075, 1966.PubMedCrossRefGoogle Scholar
  9. 9.
    McGarry, E.E., J.C. Beck, L. Ambe, and R. Nayak, Some studies with antisera to growth hormone ACTH and TSH, Rec Prog Horm Res 20: 1–31, 1964.PubMedGoogle Scholar
  10. 10.
    Tilders, FJ.H., F. Berkenbosch, I. Vermes, EA. Linton, and P.G. Smelik, Role of epinephrine and vasopressin in the control of the pituitary-adrenal response to stress, Fed Proc 44: 155–160, 1985.PubMedGoogle Scholar
  11. 11.
    Aston, R., A.T. Holder, MA. Preece, and J. Ivanyi, Potentiation of the somatogenic and lactogenic activity of human growth hormone with monoclonal antibodies, J Endocrinol 110: 381–388, 1986.PubMedCrossRefGoogle Scholar
  12. 12.
    Aston, R., and J. Ivanyi, Monoclonal antibodies to growth hormone and prolactin, Pharmacol Therap 27: 403–424, 1985.CrossRefGoogle Scholar
  13. 13.
    Shechter, Y., K.J. Chang, S. Jacobs, and P. Cuatrecasas, Modulation of binding and bioactivity of insulin by anti-insulin antibody: relation to possible role of receptor self aggregation in hormone action, Proc Natl Acad Sci USA 76: 2720–2724, 1979.PubMedCrossRefGoogle Scholar
  14. 14.
    Shechter, Y., L. Hernandez, J. Schlessinger, and P. Cuatrecasas, Local aggregation of hormone-receptor complexes is required for activation by epidermal growth factor, Nature 278: 835–838, 1979.CrossRefGoogle Scholar
  15. 15.
    Massone, A., C. Baldari, S. Censini, M. Bartalini, D. Nucci, D. Boraschi, and J.L. Telford, Mapping of biologically relevant sites on human 1L-10 using monoclonal antibodies, J Immunol 140:3812–3816,1988.PubMedGoogle Scholar
  16. 16.
    Chan, J.S.D., Z.R. Nie, N.G. Scidah, and M. Chretien, Inhibition of binding of ovine placental lactogen to growth hormone and prolactin receptors by monoclonal antibodies, Endocrinology 119: 2623–2628, 1986.PubMedCrossRefGoogle Scholar
  17. 17.
    White, A., C. Gray, and J.G. Ratcliffe, Characterization of monoclonal antibodies to adrenocor-ticotrophin, I Immunol Methods 79: 185–194, 1985.CrossRefGoogle Scholar
  18. 18.
    Van Bree, C., M. Rep, A. White, and FJ.H. Tilders, Biological activity of monoclonal antibodies to corticotropin (ACTH): relationship to peptide binding, Proceedings of the 30th Duth Federative Meeting Abstract #52, 1989.Google Scholar
  19. 19.
    Butler, J.E., The immune response to protein and protein-conjugated antigens and the possible consequences of resultant in vivo reaction, In E. Nieschlag (ed) Immunization with Hormones in Reproduction Research ,North Holland PBI, Amsterdam, pp. 11–30, 1975.Google Scholar
  20. 20.
    Rao, AJ., JA. Long, and J. Ramachandran, Effects of antiserum to adrenocorticotropin on adrenal growth and function, Endocrinology 102: 371–378, 1978.PubMedCrossRefGoogle Scholar
  21. 21.
    St. John, PA., L. Dufy-Barbe, and J.L. Barker, Anti-prolactin cell-surface immunoactivity identifies a subpopulation of lactotrophs from the rat anterior pituitary, Endocrinology 119: 2783–2795, 1986.CrossRefGoogle Scholar
  22. 22.
    Thorner, M.O., J.C. Borges, M.J. Cronin, DA. Keefer, P. Hellmann, D. Lewis, L.G. Dabney, and PJ. Quesberry, Fluorescence activated cell sorting of functional anterior pituitary cells, Endocrinology 110: 1831–1833, 1982.PubMedCrossRefGoogle Scholar
  23. 23.
    Jacobowitz, D.M., M.G. Ziegler, and JA. Thomas, In vivo uptake of antibody to dopamines-ß-hydroxylase into sympathetic elements, Brain Res 91: 165–170, 1975.PubMedCrossRefGoogle Scholar
  24. 24.
    Ziegler, M.G., JA. Thomas, and D.M. Jacobowitz, Retrograde axonal transport of antibody to dopamines-ß-hydroxylase, Brain Res 104: 390–395, 1976.PubMedCrossRefGoogle Scholar
  25. 25.
    Fillenz, M., G. Gagnon, K. Stoeckel, and H. Thoenens, Selective uptake and retrograde transport of dopamines-ß-hydroxylase antibodies in peripheral adrenergic neurons, Brain Res 114: 293–304, 1976.PubMedCrossRefGoogle Scholar
  26. 26.
    Lees, G.R., and R.J. Horsburg, Retrograde transport of dopamines-ß-hydroxylase antibodies in sympathetic neurons: effects of drugs modifying noradrenergic transmission, Brain Res 301:281–286,1984.PubMedCrossRefGoogle Scholar
  27. 27.
    Lees, G., I. Geffen, and R. Rush, Phentolamine increases neuronal binding and retrograde transport of dopamines-ß-hydroxylase antibodies, Neurosci Lett 22: 115–118, 1981.PubMedCrossRefGoogle Scholar
  28. 28.
    Ling, G., R. Fischer-Colbri, W. Schmidt, and H. Winkler, Exposure of an antigen of chromaffin granules on cell surface during exocytosis, Nature 301: 610–611, 1983.CrossRefGoogle Scholar
  29. 29.
    Chan Palay, V., S.L. Pallay, J.Y. Wu, Gamma-aminobutyric acid pathways in the cerebellum studied by retrograde and anterograde transport of glutamic acid decarboxylase antibody after in vivo injections, Anat Embryol 157: 1–14, 1979.PubMedCrossRefGoogle Scholar
  30. 30.
    Costa, M., RA. Rust, J.B. Furness, and L.B. Geffen, Histochemical evidence for the degeneration of peripheral noradrenergic axons following intravenous injection of antibodies to dopamines-ß-hydroxylase, Neurosci Lett 3: 201–207, 1976.PubMedCrossRefGoogle Scholar
  31. 31.
    Furness, J.B., S.Y. Lewis, R. Rush, M. Costa, and L.B. Geffen, Involvement of complement of degeneration of sympathetic nerves after administration of antiserum to dopamines-ß-hydroxylase, Brain Res 136: 67–75, 1977.PubMedCrossRefGoogle Scholar
  32. 32.
    Lewis, S.Y., RA. Rush, and L.B. Geffen, Biochemical effects on guinea pig iris of local injection of dopamines-ß-hydroxylase antibodies and F(ab)2 fragments, Brain Res 134: 173–179, 1977.PubMedCrossRefGoogle Scholar
  33. 33.
    Blessing, W.W., M. Costa, L.B. Geffen, RA. Rush, and G. Fink, Immune lesions of noradrenergic neurons in rat central nervous system produced by antibodies to dopamines-ß-hydroxylase, Nature 267: 368–369, 1977.PubMedCrossRefGoogle Scholar
  34. 34.
    Costa, M., L.B. Geffen, RA. Rush, D. Brigges, W.W. Blessing, and J.W. Health, Immuno lesions of central noradrenergic neurons produced by antibodies to dopamines-ß-hydroxylase, Brain Res 173:65–78, 1979.PubMedCrossRefGoogle Scholar
  35. 35.
    Rush, RA., M. Costa, J.B. Furness, and L.B. Geffen, Changes in tyrosine hydroxylase and dopamines-ß-hydroxylase activities during degeneration of noradrenergic axons produced by antibodies to dopamines-ß-hydroxylase, Neurosci Lett 3: 209–213, 1976.PubMedCrossRefGoogle Scholar
  36. 36.
    Campbell, A.K., RA. Daw, and P.J. Luzio, Rapid increase in intracellular free Ca++ induced by antibody plus complement, FEBS Lett 107: 55–60, 1979.PubMedCrossRefGoogle Scholar
  37. 37.
    Schweizer, E.S., and M.P. Blaustein, The use of antibody and complement to gain access to the interior of presynaptic nerve terminals, Exper Brain Res 38: 443–453, 1980.Google Scholar
  38. 38.
    Docherty, M., H.F. Bradford, B. Anderton, and J.Y. Wu, Specific lysis of GABAergic synaptosomes by an antiserum to glutamate decarboxylase, FEBS Lett 152: 57–61, 1983.PubMedCrossRefGoogle Scholar
  39. 39.
    Docherty, M., H.F. Bradford, C.D. Cash, and M. Maitre, Specific immunolysis of serotonergic nerve terminals using an antiserum against tryptophan hydroxylase, FEBS Lett 182: 489–492, 1985.PubMedCrossRefGoogle Scholar
  40. 40.
    Docherty, M., H.F. Bradford, J.Y. Wu, T.H. Joh, and J.D. Reis, Evidence for specific immunolysis of nerve terminals using antisera against choline acetyltransferase, glutamate decarboxylase and tyrosine hydroxylase, Brain Res 339: 105–113, 1985.PubMedCrossRefGoogle Scholar
  41. 41.
    Docherty, M., H.F. Bradford, and T.H. Joh, Specific lysis of noradrenergic synaptosomes by an antiserum to dopamines-ß-hydroxylase, FEBS Lett 202: 37–40, 1986.PubMedCrossRefGoogle Scholar
  42. 42.
    Chan Palay, V., Immunocytochemical detection of substance P neurons their processes and connections by in vivo microinjections of monoclonal antibodies, Anat Embryol 156: 225–240, 1979.CrossRefGoogle Scholar
  43. 43.
    Burlet, A.J., B.P. Leon-Henri, F.R. Robert, A. Abrahmani, B.M.L. Fernette, and C.R. Burlet, Monoclonal anti-vasopressin (VP) antibodies penetrate into VP neurons in vivo, Exper Brain Res 65: 629–638, 1987.Google Scholar
  44. 44.
    Leon-Henri, B., A. Burlet, J. Chauvet, J. Nicolas, and C. Burlet, Vasopressin neuron is the target of monoclonal antibodies raised against vasopressin-neurophysin injected in vivo, Neuroendocrinology 49: 125–133, 1989.PubMedCrossRefGoogle Scholar
  45. 45.
    Haumont-Pellegri, B., A. Burlet, F. Giannangeli, J-P. Nicolas, and C. Burlet, Creation d’un diabete insipide d’origine centrale induit par microinjection intrahypothalamique d’un anticorps anti-vasopressine, Ann Endocrinol [Paris] 49: 30 N, 1988.Google Scholar
  46. 46.
    Busbridge, N.J., M.J. Dascombo, F.J.H. Tilders, J.W.A.M. van Oers, E.A. Linton, and N.J. Rothwell, Central activation of thermogenesis and fever by interleukin 1ß and interleukin lα involve different mechanisms, Biochem Biophys Res Commun 162: 591–596, 1989.PubMedCrossRefGoogle Scholar
  47. Burlet, A.J., F. Menzaghi, F.J.H. Tilders, J.W.A.M. van Oers, M.P. Nicholas, and C.R. Burlet, Uptake of a monoclonal antibody directed against corticotropin releasing factor in hypothalamic neurons, Brain Res ,In Press.Google Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • F. J. H. Tilders
    • 1
  • J. W. A. M. van Oers
    • 1
  • A. White
    • 1
  • F. Menzaghi
    • 1
  • A. Burlet
    • 1
  1. 1.Department of PharmacologyFree UniversityAmsterdamThe Netherlands

Personalised recommendations